Business Standard

Monday, December 23, 2024 | 10:10 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Takeda Pharmaceutical to sell Japan health business to Blackstone

Japan's largest pharmaceuticals company has been selling its over-the-counter (OTC) assets worldwide

Takeda Pharmaceutical
Premium

Takeda Pharmaceutical (Reuters)

Reuters Tokyo
Takeda Pharmaceutical Co said on Monday it would sell its Japanese consumer healthcare business to US buyout fund Blackstone Group , as it aims to focus on developing drugs for unmet medical needs and rare diseases.

Japan's largest pharmaceuticals company has been selling its over-the-counter (OTC) assets worldwide as it seeks to refocus its business and reduce debt following a $59 billion acquisition of Shire Plc last year.

Takeda CEO Christophe Weber said via an online briefing the company had decided to sell the Japanese OTC unit because it would be difficult for Takeda to keep investing in OTC businesses while trying

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in